FilingReader Intelligence
Legend Biotech reports $439m CARVYKTI sales for Q2
July 16, 2025 at 01:10 PM UTC•By FilingReader AI
Legend Biotech reported preliminary net trade sales of approximately $439 million for CARVYKTI during the quarter ended June 30, 2025.
The sales figure stems from the collaboration agreement with Janssen Biotech and is based on data provided by Janssen.
This report was generated by FilingReader's AI system from regulatory filings and company disclosures. To request a correction, contact editorial@filingreader.com
HKEX:1548•Hong Kong Exchange
News Alerts
Get instant email alerts when Genscript Biotech Corp publishes news
Free account required • Unsubscribe anytime